TABLE 1.

Demographic, radiological, and microbiological data of patients suffering from aspergillosis

Patient	Gender	Underlying conditiona	Aspergillosis diagnosis	Prophylaxis	HRCT	GM	PCR resulte	Days before HRCTf	Days before GMg
1	Male	ALL	Provenb	Fluconazole/itraconazole	Positive	Positive	Positive	67	65
2	Male	NHL	Probable	None	Positive	Positive	Positive	0	0
3	Female	AML	Probable	Itraconazole	Positive	Positive	Positive	−27	−28
4	Female	AML	Probable	Itraconazole	Positive	Positive	Positive	61	199
5	Female	MM	Probable	Fluconazole	Negativec	Positive	Positive	0	0
6	Male	AML	Probable	Itraconazole	Positive	Positive	Positive	1	37
7	Male	ALL	Probable	Itraconazole	Positive	Negatived	Positive	84	79
8	Female	AML	Probable	Itraconazole	Positive	Positive	Positive	19	107
9	Male	ALL	Probable	Itraconazole	Positive	Positive	Positive	90	154
10	Female	AML	Probable	Itraconazole	Positive	Positive	Negative	NCh	NC
11	Male	MDS	Possible	Itraconazole	Positive	Negative	Positive	−69	NC
12	Male	AML	Possible	Itraconazole	Positive	Negative	Positive	8	NC

^aALL, acute lymphoblastic leukemia; NHL, non-Hodgkin's lymphoma; AML, acute myeloblastic leukemia; MM, multiple myeloma; MDS, myelodysplasic syndrome.

^bProven aspergillosis by positive culture from tissue biopsies.

^cPatient was diagnosed with sinonasal aspergillosis after imaging showing sinusitis.

^dPatient was diagnosed by sputum culture with A. fumigatus.

^eThe table includes analysis taking into account only two or more positive PCR results.

^fTime in days taken by the PCR-based technique to detect Aspergillus DNA before signs appeared on HRCT; a minus sign indicates that fungal DNA was detected later than signs on the HRCT.

^gTime in days taken by the PCR-based technique to detect Aspergillus DNA before the GM test was positive; a minus sign indicates that fungal DNA was detected after the GM test was positive. For patient 7, the calculation was made using the date the sputum culture was positive.

^hNC, not calculated. Values were not calculated because the test was negative.